FarmaKology

By Abdul Menum Ali

FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "abdul@farmakology.com".

FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "abdul@farmakology.com".

By subscribing, you agree with Revue’s Terms of Service and Privacy Policy and understand that FarmaKology will receive your email address.

5.1K

subscribers

88

issues

#88・

FarmaKology-Existing cancer drugs could become new Alzheimer’s treatments

Jazz PharmaceuticalsJazz Pharmaceuticals , is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often wi…

 
#87・

FarmaKology -New drug offers hope for pancreatic cancer patients

Arbor BiotechnologiesArbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synth…

 
#86・

FarmaKology -Pfizer's Covid Antiviral Appears to Work Really, Really Well

Neoleukin TherapeuticsNeoleukin is a pioneer in de novo protein development, leveraging computational methods to create new therapies. This new approach has unlimited potential to treat human disease by improving on nature, designing for life. We are building…

 
#85・

FarmaKology -Molecular Agent Designed To Image and Treat Tumors

DNAeDNAe is a pioneering molecular diagnostics company developing solutions which enable rapid near-patient, real-time diagnostics. The innovative application of DNAe’s semiconductor technology in LiDiaTM diagnostic products allows us to combine powerful anal…

 
#84・

FarmaKology Newsletter - Issue #84

PsygenPsygen is a leading pharmaceutical-grade psychedelic supply chain solution for clinicians and researchers with the world’s first dedicated, GMP compliant, state-of-the-art, large-scale manufacturing facility.

 
#83・

FarmaKology Newsletter - Issue #83

JanOne JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for prescribing dangerous opioid d…

 
#82・

FarmaKology Newsletter - Issue #82

Checkmate PharmaceuticalsCheckmate Pharmaceuticals is a clinical stage biotechnology company focused on developing proprietary technology to harness the power of the immune system to combat cancer. Checkmate’s product candidate, vidutolimod (CMP-001), is a di…

 
#81・

FarmaKology Newsletter - Issue #81

MOGRIFYMogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems …

 
#80・

FarmaKology Newsletter - Issue #80

Maintaining pace through the digital shift poses a perpetual challenge to pharma. With analytics identified and anchored as the cornerstone for data-driven decisions, you need to discuss how to implement and execute emerging commercial strategies in a hybrid …

 
#79・

FarmaKology Newsletter - Issue #79

DECISION-MAKING FOR GENERIC DRUG ENTRY AND BRANDED DRUG LIFECYCLE MANAGEMENT

 
#78・

FarmaKology Newsletter - Issue #78

DECISION-MAKING FOR GENERIC DRUG ENTRY AND BRANDED DRUG LIFECYCLE MANAGEMENT

 
#77・

FarmaKology Newsletter - Issue #77

DECISION-MAKING FOR GENERIC DRUG ENTRY AND BRANDED DRUG LIFECYCLE MANAGEMENT

 
#76・

FarmaKology Newsletter - Issue #76

We’ve entered a new era. One where being risk-averse is the riskiest strategy, long-established operating models have been torn up and reimagined, and where investment in digital innovation – both cultural and financial – has ignited.

 
#75・

FarmaKology Newsletter - Issue #75

bit.biobit.bio is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing con…

 
#74・

FarmaKology Newsletter - Issue #74

uFraction8uFraction8 builds products around a disruptive new liquid particle processing technology. Following our world-leading research, establishing new levels of throughput for massively multiplexed microfluidic devices, our technology will be the key to u…

 
#73・

FarmaKology Newsletter - Issue #73

REVOLUTION MedicinesREVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. Our innovative product engine draws inspiration from nature and evolution, which offer …

 
#72・

FarmaKology Newsletter - Issue #72

Relay TherapeuticsRelay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines u…

 
#71・

FarmaKology Newsletter - Issue #71

Adagio TherapeuticsAdagio Therapeutics, Inc. is a clinical-stage biotechnology company developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional pre-emergent coronaviruses. Our candidates are optimized using Adimab’…

 
#70・

FarmaKology Newsletter - Issue #70

Gel4Med Gel4Med is an early stage regenerative medicine company focused on developing our Therapeutic Materials Platform to address unmet clinical needs in soft tissue regeneration. Gel4Med, the Smart Materials Company paving the way to the future of regenera…

 
#69・

FarmaKology Newsletter - Issue #69

Force TherapeuticsForce Therapeutics is a powerful, episode-based digital care platform and research network designed to help clinicians intelligently extend their reach. Our platform leverages video and digital connections to directly engage patients at ever…